+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Endometriosis Treatment Market Research Report by Drug Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989704
  • Report
  • July 2021
  • Region: Global
  • 183 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Endometriosis Treatment Market will Grow to USD 3,520.13 Million by 2026, at a CAGR of 7.17%

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Eli Lilly and Company
The Global Endometriosis Treatment Market size was estimated at USD 2,322.54 Million in 2020 and expected to reach USD 2,481.36 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.17% to reach USD 3,520.13 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Endometriosis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the Endometriosis Treatment Market was examined across GnRH Analogues, LNR-IUDS, NSAIDs, Oral Contraceptives, and Progestins.
  • Based on Treatment Type, the Endometriosis Treatment Market was examined across Hormonal Therapy and Pain Management.
  • Based on Distribution Channel, the Endometriosis Treatment Market was examined across E-commerce, Hospital, Pharmacies, and Retail Pharmacies.
  • Based on Geography, the Endometriosis Treatment Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Endometriosis Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Endometriosis Treatment Market, including Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Eli Lilly and Company, Ipsen, Meditrina Pharmaceuticals Private Limited, Myovant Sciences Ltd, Neurocrine Biosciences Inc., Orphagen Pharmaceuticals, Inc., Pfizer Inc., Philogen, and Takeda Pharmaceutical Company.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Endometriosis Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Endometriosis Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Endometriosis Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Endometriosis Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Endometriosis Treatment Market?
6. What is the market share of the leading vendors in the Global Endometriosis Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Endometriosis Treatment Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Eli Lilly and Company
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug Type Outlook
3.4. Treatment Type Outlook
3.5. Distribution Channel Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence rate of endometriosis
5.1.1.2. Increase in the female population within the reproductive age
5.1.1.3. Presence of novel drugs
5.1.2. Restraints
5.1.2.1. Lack of non-invasive diagnostics
5.1.3. Opportunities
5.1.3.1. Rise in research activities for development of new drugs and treatment methodologies
5.1.3.2. Rising use nanotechnology to develop new treatment for endometriosis
5.1.4. Challenges
5.1.4.1. Presence of alternative treatment such as Intrauterine Systems (IUS)
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Endometriosis Treatment Market, by Drug Type
6.1. Introduction
6.2. GnRH Analogues
6.3. LNR-IUDS
6.4. NSAIDs
6.5. Oral Contraceptives
6.6. Progestins

7. Endometriosis Treatment Market, by Treatment Type
7.1. Introduction
7.2. Hormonal Therapy
7.3. Pain Management

8. Endometriosis Treatment Market, by Distribution Channel
8.1. Introduction
8.2. E-commerce
8.3. Hospital
8.4. Pharmacies
8.5. Retail Pharmacies

9. Americas Endometriosis Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Endometriosis Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Endometriosis Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. AbbVie Inc.
13.3. Astellas Pharma Inc.
13.4. AstraZeneca PLC
13.5. Bayer AG
13.6. Eli Lilly and Company
13.7. Ipsen
13.8. Meditrina Pharmaceuticals Private Limited
13.9. Myovant Sciences Ltd
13.10. Neurocrine Biosciences Inc.
13.11. Orphagen Pharmaceuticals, Inc.
13.12. Pfizer Inc.
13.13. Philogen
13.14. Takeda Pharmaceutical Company

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2026
FIGURE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (%)
FIGURE 23. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2026
FIGURE 25. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 30. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 32. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 40. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 41. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 43. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 44. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 45. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 46. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 49. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 51. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 52. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 53. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 54. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 55. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 64. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 72. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 74. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 75. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 18. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 19. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 22. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 23. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 24. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 25. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 26. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 27. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 28. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 29. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 30. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 31. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 32. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 33. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 34. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 35. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 36. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 39. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 40. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 41. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 42. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 43. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 44. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 45. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 46. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 47. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 48. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 49. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 50. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 51. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 52. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 53. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 54. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 55. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 56. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 57. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 58. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 59. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 60. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 61. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 62. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 63. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 64. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 65. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 66. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 67. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 68. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 69. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 70. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 71. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 76. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 77. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 78. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 79. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 80. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 81. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 82. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 83. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 84. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 85. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 86. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 87. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 88. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 89. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 90. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 91. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 92. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 93. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 94. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 95. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 96. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 97. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 98. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 99. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 100. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 101. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 102. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 105. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 106. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 107. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2026 (USD MILLION)
TABLE 108. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 109. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: SCORES
TABLE 110. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: BUSINESS STRATEGY
TABLE 111. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 112. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: RANKING
TABLE 113. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 114. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: MERGER & ACQUISITION
TABLE 115. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 116. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 117. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 118. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 119. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Eli Lilly and Company
  • Ipsen
  • Meditrina Pharmaceuticals Private Limited
  • Myovant Sciences Ltd
  • Neurocrine Biosciences Inc.
  • Orphagen Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Philogen
  • Takeda Pharmaceutical Company
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll